Hot Pursuit     10-Mar-25
Zydus Life gets USFDA approval for Ketoconazole Shampoo, 2%
Zydus Lifesciences announced that it has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Ketoconazole shampoo, 2%.
Ketoconazole shampoo, a generic version of Nizoral Shampoo (2%), is an antifungal medication used to treat dandruff, fungal infections, and other skin conditions. It will be produced at the group’s topical manufacturing site at Changodar, Ahmedabad.

According to IQVIA MAT data for January 2025, Ketoconazole shampoo had annual sales of $68.89 million in the United States.

With this approval, Zydus Lifesciences now holds 418 USFDA approvals, having filed 483 ANDAs since FY 2003-04.

Zydus Lifesciences is a discovery-driven, global life sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies.

The company reported a 29.62% jump in consolidated net profit of Rs 1,023.5 crore in Q3 FY25 compared with Rs 789.6 crore in Q3 FY24. Revenue from operations increased 16.96% YoY to Rs 5,269.1 crore during the quarter.

Shares of Zydus Lifesciences rose 0.67% to Rs 907.20 on the BSE.

Previous News
  Zydus Life gets USFDA nod for Zituvimet XR tablets
 ( Hot Pursuit - 19-Jul-24   11:53 )
  Zydus Lifesciences Q3 PAT jumps 30% YoY to Rs 1,023 cr
 ( Hot Pursuit - 05-Feb-25   15:20 )
  Zydus receives USFDA approval for Zituvimet™ XR tablets
 ( Corporate News - 19-Jul-24   13:58 )
  Zydus Lifesciences receives USFDA approval for Scopolamine Transdermal System
 ( Corporate News - 30-Aug-24   15:12 )
  Zydus completes acquisition of 50% stake in Sterling Biotech
 ( Corporate News - 30-Aug-24   11:21 )
  Zydus and Dr Reddy's ink licensing agreement to co-market Pertuzumab in India
 ( Corporate News - 28-Jun-24   19:04 )
  Zydus Life gains on USFDA nod for phase 2 clinical trial of ZYIL1
 ( Hot Pursuit - 18-Dec-23   09:22 )
  Volumes spurt at Zydus Lifesciences Ltd counter
 ( Hot Pursuit - 18-Dec-23   11:00 )
  Zydus Lifesciences to table results
 ( Corporate News - 21-Jan-25   14:18 )
  Indices trade near flat line; Media shares rally
 ( Market Commentary - Mid-Session 18-May-24   10:32 )
  Zydus announces NDA acceptance of Desidustat in China by NMPA
 ( Corporate News - 23-Apr-24   16:06 )
Other Stories
  Kamat Hotels Q4 PAT surges 412% YoY to Rs 11 cr
  26-Apr-25   16:21
  Bank of Maharashtra Q4 PAT climbs 23% YoY to Rs 1,493 crore
  26-Apr-25   15:34
  Oracle Financial Services Software Q4 PAT up 19% QoQ
  26-Apr-25   14:28
  Force Motors Q4 PAT surges 210% YoY to Rs 435 cr; declares dividend of Rs 40/sh
  26-Apr-25   14:02
  L&T Finance Q4 PAT rises 15% YoY to Rs 636 crore
  26-Apr-25   13:31
  RBL Bank PAT drops 81% YoY to Rs 69 crore in Q4 FY25; provisions zoom by 90% YoY
  26-Apr-25   12:12
  Tejas Networks reports dismal Q4 outcome
  26-Apr-25   11:54
  Zydus Life gets 6 observations from USFDA for API plant
  26-Apr-25   11:02
  RIL Q4 PAT rises 6.4% YoY
  26-Apr-25   10:05
  Tata Technologies Q4 PAT climbs 12% QoQ to Rs 189 cr
  25-Apr-25   17:34
Back Top